Hypertension Flashcards
ACEi
ex. ramipril
AE: dry cough, acute increase in SCr, hyperkalemia, angioedema
CI: pregnancy
DDI: lithium
Caution: bilateral renal artery stenosis
ACE+CCB>ACE+diuretic
ARB
ex. candesartan
AE: acute increase in SCr, hyperkalemia, angioedema (less than ARB)
CI: pregnancy
DDI: lithium
Caution: bilateral renal artery stenosis
Aliskiren (direct renin inhibitor)
AE: diarrhea, cough, rash, fatigue
CI: pregnancy
Thiazide diuretics
Hydrochlorothiazide
AE: hypokalemia, hyponatremia, hyperuricemia, hyperglycemia, hyperlipidemia
DDI: lithium
Thiazide-like diuretics
Chlorthalidone, indapamide, metolazone
*preferred over thiazides bc additionally lowers coronary events and all cause mortality plus longer half life
AE: hypokalemia, hyponatremia, hyperuricemia
DHP CCB
eg. amlodipine, nifedipine ER
vascular selective, vasodilate to reduce BP
AE: ankle edema, flushing, headache, palpitations (reflex tachycardia)
non-DHP CCB
eg. verapamil, diltazem
non-vascular selective, vasodilate (reduce BP) and affect heart (decrease HR; no reflex tachycardia)
AE: headache, dizziness, bradycardia, worsening HF, constipation (V)
BB
AE: bradycardia, sleep disturbances, hypoglycemia (if on insulin), increase TG, decrease HDL
Caution: heart block, asthma, elderly (avoid monotx in >60y)
Taper; can cause withdrawal
nonselective BB
cardioselective BB
intrinsic sympathomimetic BB
a1 blocking BB
vasodilating BB
nonselective: propanolol, nadolol, sotalol, timolol
cardioselective: metoprolol, bisoprolol, atenolol, acebutolol - safer in asthma, diabetes
ISA: pindolol, acebutolol, penbutolol - less bradycardia
a1: labetolol, carvedilol - no reflex tachycardia
vasodilating: cartelol, carvedilol, labetolol - beneficial in HF
Pregnancy antihypertensives
1st line: labetolol, methyldopa, nifedipine ER, other BB (acebutolol, propanolol, metoprolol, pindolol)
2nd line: clonidine, hydralazine
AVOID: ACE/ARB, atenolol, spironolactone, diuretics
alpha antagonists
prazosin, doxazosin
AE: ortho hypo, headache, drowsiness, nasal congestion, syncope
MRA
Mineralocorticoid Receptor Antagonists
Epleronone, Spironolactone
Monitor K, SCr
maybe effective in resistant HTN (tried >3 drugs)
What BP to go to ER
> 200/120mmHg
What BP is pharmacotx indicated?
> 160/100mmHg
new antihypertensive, when to follow up? increase dose?
2-4w follow up, 4w increase dose